A longitudinal study of microdosing psilocybin as a treatment for mild/moderate depression

  • Polito, Vince (Primary Chief Investigator)
  • Brett, Jonathan (Chief Investigator)
  • Bayes, Adam (Chief Investigator)
  • Stevenson, Dick (Chief Investigator)
  • Liknaitzky, Paul (Chief Investigator)
  • Rodgers, Anthony (Chief Investigator)
  • Sowman, Paul (Associate Investigator)
  • Jones, Mike (Associate Investigator)
  • Shaheen, Nargis (Associate Investigator)
  • Kang, Melissa (Associate Investigator)
  • Holdenson Kimura, Phoebe (Associate Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)

Project: Research

Project Details

Description

A longitudinal placebo controlled clinical trial to investigate the efficacy and safety of microdoses of psilocybin (approx 5mg) as a treatment for mild-moderate depression.
StatusFinished
Effective start/end date14/04/22 → 30/10/22